Antibiotic effects on bacterial profile in osteonecrosis of the jaw

Oral Diseases

Volumn 18, Issue 1, 2012, Pages 85-95

  Ji, X ^a   Pushalkar, S ^b   Li, Y ^b   Glickman, R ^b   Fleisher, K ^b   Saxena, D ^b  

^a POLYTECHNIC UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Antibiotics; BRONJ; DGGE; Microbial diversity

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; RNA 16S; TETRACYCLINE;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM; BACTERIUM CULTURE; CLINICAL ARTICLE; COHORT ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; FIRMICUTES; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; JAW OSTEONECROSIS; LACTOBACILLUS GASSERI; MALE; MICROBIAL DIVERSITY; MOGIBACTERIUM TIMIDUM; NONHUMAN; PARVIMONAS MICRA; PRIORITY JOURNAL; SOLOBACTERIUM MOOREI; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS INTERMEDIUS;

AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BIODIVERSITY; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; CIPROFLOXACIN; CLUSTER ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA, BACTERIAL; DOXYCYCLINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; TETRACYCLINE;

EID: 84155164311     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01848.x     Document Type: Article

References (78)

1. Abraham F, Dalvi M, Farooki A et al (2009). Molecular analysis of bacteria associated with osteonecrosis of the jaw (abstract). J Dent Res 88: A3441.
2. Allam E, Allen M, Chu TM et al (2011). In vivo effects of zoledronic acid on oral mucosal epithelial cells. Oral Dis 17: 291-297.
3. Allen MR, Burr DB (2009). The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67: 61-70.
4. Arif N, Sheehy EC, Do T et al (2008). Diversity of Veillonella spp. from sound and carious sites in children. J Dent Res 87: 278-282.
5. Bamias A, Kastritis E, Bamia C et al (2005). Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23: 8580-8587.
6. Bertoldo F, Santini D, Lo Cascio V (2007). Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. Nat Clin Pract Oncol 4: 711-721.
7. Carlson ER, Basile JD (2009). The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxil Surg 67: 85-95.
8. Cole JR, Wang Q, Cardenas E et al (2009). The ribosomal database project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37: D141-D145.
9. Coleman RE (2008). Risks and benefits of bisphosphonates. Br J Cancer 98: 1736-1740.
10. Colwell RK (2009). EstimateS: statistical estimation of species richness and shared species from samples. Version 8.2. User's guide and application published at: or (accessed 22 December 2010).
11. DeSantis TZ Jr, Hugenholtz P, Keller K et al (2006a). NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res 34: W394-W399.
12. DeSantis TZ, Hugenholtz P, Larsen N et al (2006b). Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72: 5069-5072.
13. Diaz PI, Chalmers NI, Rickard AH et al (2006). Molecular characterization of subject-specific oral microflora during initial colonization of enamel. Appl Environ Microbiol 72: 2837-2848.
14. Diel IJ, Fogelman I, Al-Nawas B et al (2007). Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino- and non-aminobisphosphonates? Crit Rev Oncol Hematol 64: 198-207.
15. Dodson TB (2009). Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67: 44-52.
16. Donlan RM, Costerton JW (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
17. Ertas U, Tozoglu S, Gursan N (2004). Chronic osteomyelitis: 20years after mandible fracture. Dent Traumatol 20: 106-108.
18. Estilo CL, Van Poznak CH, Wiliams T et al (2008). Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist 13: 911-920.
19. Fantasia JE (2009). Bisphosphonates-what the dentist needs to know: practical considerations. J Oral Maxil Surg 67: 53-60.
20. Fleisher KE, Doty S, Kottal S et al (2008). Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note. J Oral Maxillofac Surg 66: 2646-2653.
21. Gebara SN, Moubayed H (2009). Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates. Am J Health Syst Pharm 66: 1541-1547.
22. Gliklich R, Wilson J (2009). Epidemiology of bisphosphonate-related osteonecrosis of the jaws: the utility of a national registry. J Oral Maxillofac Surg 67: 71-74.
23. Goldie MP (2009). What is new in research? Int J Dent Hyg 7: 226-228.
24. Good IJ (1953). The population frequencies of species and the estimation of population parameters. Biometrika 40: 237-264.
25. Gray T (2005). Streptococcus anginosus group: clinical significance of an important group of pathogens. Clin Microbiol Newsl 27: 155-159.
26. Hammer Ø, Harper DAT, Ryan PD (2001). PAST: paleontological statistics software package for education and data analysis. Palaeontol Electronica 4: 9.
27. Hoefert S, Eufinger H (2011). Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 69: 362-380.
28. Hoefert S, Schmitz I, Tannapfel A et al (2010). Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig 14: 271-284.
29. Hoff AO, Toth BB, Altundag K et al (2008). Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Min Res. 23: 826-836.
30. Hooper SJ, Crean S-J, Fardy MJ et al (2007). A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol 56: 1651-1659.
31. Jenkinson HF, Lamont RJ (2005). Oral microbial communities in sickness and in health. Trends Microbiol 13: 589-595.
32. Kamel HK (2007). Update on osteoporosis management in long-term care: focus on bisphosphonates. J Am Med Dir Assoc 8: 434-440.
33. Kaplan I (2010). In reply. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 109: 657-658.
34. Kaplan I, Anavi K, Anavi Y et al (2009). The clinical spectrum of Actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 108: 738-746.
35. Kassolis JD, Scheper M, Jham B et al (2010). Histopathologic findings in bone from edentulous alveolar ridges: a role in osteonecrosis of the jaws? Bone 47: 127-130.
36. Kazor CE, Mitchell PM, Lee AM et al (2003). Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol 41: 558-563.
37. Kemp PF, Aller JY (2004). Estimating prokaryotic diversity: when are 16S rDNA libraries large enough? Limnol Oceanogr-Meth 2: 114-125.
38. Kos M (2011) Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation. Med Hypotheses 77: 214-215.
39. Kos M, Luczak K (2009). Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation. Biosci Hypotheses 2: 34-36.
40. Krueger CD, West PM, Sargent M et al (2007). Bisphosphonate-induced osteonecrosis of the jaw. Ann Pharmacother 41: 276-284.
41. Kumar SK, Gorur A, Schaudinn C et al (2010). The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy. Curr Osteoporos Rep 8: 40-48.
42. Kuramitsu HK, He XS, Lux R et al (2007). Interspecies interactions within oral microbial communities. Microbiol Mol Biol R 71: 653-670.
43. Kyrgidis A, Tzellos TG, Toulis K et al (2011). The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications. J Osteoporos 2011: Article ID 147689.
44. Lane DJ (1991). 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M, eds. Nucleic acid techniques in bacterial systematics. John Wiley & sons Ltd: West Sussex, UK, pp. 115-147.
45. Larkin MA, Blackshields G, Brown NP et al (2007). Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
46. Lazar V, Chifiriuc MC (2010). Medical significance and new therapeutical strategies for biofilm associated infections. Roum Arch Microbiol Immunol 69: 125-138.
47. Lesclous P, Abi Najm S, Carrel JP et al (2009). Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45: 843-852.
48. Li Y, Ku CYS, Xu J et al (2005). Survey of oral microbial diversity using PCR-based denaturing gradient gel electrophoresis. J Dent Res 84: 559-564.
49. Li Y, Saxena D, Barnes VM et al (2006). Polymerase chain reaction-based denaturing gradient gel electrophoresis in the evaluation of oral microbiota. Oral Microbiol Immun 21: 333-339.
50. Li Y, Ge Y, Saxena D et al (2007). Genetic profiling of the oral microbiota associated with severe early-childhood caries. J Clin Microbiol 45: 81-87.
51. Migliorati CA, Schubert MM, Peterson DE et al (2005). Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104: 83-93.
52. Montefusco V, Gay F, Spina F et al (2008). Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leuk Lymphoma 49: 2156-2162.
53. Naik NH, Russo TA (2009). Bisphosphonate-related osteonecrosis of the jaw: the role of Actinomyces. Clin Infect Dis 49: 1729-1732.
54. Nair SP, Meghji S, Wilson M et al (1996). Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 64: 2371-2380.
55. Ota-Tsuzuki C, Mayer MPA (2010). Collagenase production and hemolytic activity related to 16S rRNA variability among Parvimonas micra oral isolates. Anaerobe 16: 38-42.
56. Otto S, Hafner S, Grotz KA (2009). The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 67: 589-592.
57. Pautke C, Bauer F, Otto S et al (2011). Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg 69: 84-91.
58. Pazianas M (2011). Osteonecrosis of the jaw and the role of macrophages. J Natl Cancer Inst 103: 232-240.
59. Pei Z, Bini EJ, Yang L et al (2004). Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A 101: 4250-4255.
60. Pushalkar S, Mane SP, Ji X et al (2011). Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol 61: 269-277.
61. Reid IR (2009). Osteonecrosis of the jaw: who gets it, and why? Bone 44: 4-10.
62. Rocas IN, Siqueira JF (2008). Root canal microbiota of teeth with chronic apical periodontitis. J Clin Microbiol 46: 3599-3606.
63. Rochford JC (1980). Pleuropulmonary infection associated with Eubacterium-Brachy, a new species of Eubacterium. J Clin Microbiol 12: 722-723.
64. Ruggiero SL (2011). Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 1218: 38-46.
65. Ruggiero SL, Dodson TB, Assael LA et al (2009). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 67: 2-12.
66. Rupf S, Merte K, Eschrich K (1999). Quantification of bacteria in oral samples by competitive polymerase chain reaction. J Dent Res 78: 850-856.
67. Sedghizadeh PP, Kumar SK, Gorur A et al (2008). Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 66: 767-775.
68. Sedghizadeh PP, Kumar SK, Gorur A et al (2009). Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 140: 1259-1265.
69. Sheffield VC, Cox DR, Lerman LS et al (1989). Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci U S A 86: 232-236.
70. Smoot LM, Smoot JC, Smidt H et al (2005). DNA microarrays as salivary diagnostic tools for characterizing the oral cavity's microbial community. Adv Dent Res 18: 6-11.
71. Tuzuner-Oncul AM, Ungor C, Dede U et al (2009). Methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis of the mandible. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 107: e1-e4.
72. Van den Wyngaert T, Huizing MT, Vermorken JB (2007). Osteonecrosis of the jaw related to the use of bisphosphonates. Curr Opin Oncol 19: 315-322.
73. Vescovi P, Nammour S (2010). Bisphosphonate-related osteonecrosis of the jaw (BRONJ) therapy. A critical review. Minerva Stomatol 59: 181-203, 204-213.
74. Vickerman MM, Brossard KA, Funk DB et al (2007). Phylogenetic analysis of bacterial and archaeal species in symptomatic and asymptomatic endodontic infections. J Med Microbiol 56: 110-118.
75. Wade W (2002). Unculturable bacteria-the uncharacterized organisms that cause oral infections. J R Soc Med 95: 81-83.
76. Wessel JH, Dodson TB, Zavras AI (2008). Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J Oral Maxillofac Surg 66: 625-631.
77. Williamson RA (2010). Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 39: 251-255.
78. Wong CY, Wei X, Pushalkar S et al (2010). Evaluating bone microbiota in bisphosphonate related osteonecrosis of the jaw (abstract). J Dent Res 89: A578.